Gossamer Bio Logo
US38341P2011
A42M0V

Gossamer Bio

Loading quotes...

Forecast

The analysts' average price target is €3.01. The median is €2.60.

Buy
  10
Hold
  5
Sell
  2

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, Gossamer Bio had revenue of €8.09m and net profit of €14.81m
(EUR) June 2026
YoY
Revenue 8.09m 16.96%
Gross profit 8.09m 16.96%
Net profit 14.81m 145.60%
EBITDA -62.64m 109.05%

Fundamentals

Metric Value
Market capitalization
€56.68m
Number of shares
6.11m
52-week high/low
€268.37 - €7.91
Dividends No
Beta
2.00
P/E ratio
-0.24
PEG ratio
0.08
P/B ratio
-0.31
P/S ratio
1.23

Company profile

Name
Gossamer Bio
CEO
Faheem Hasnain
Employees 162
🍪

Parqet  uses cookies. Learn more